Mucocutaneous Manifestations of Inflammatory Bowel Disease
- PMID: 34548985
- PMCID: PMC8439267
- DOI: 10.7759/cureus.17191
Mucocutaneous Manifestations of Inflammatory Bowel Disease
Abstract
Inflammatory bowel disease (IBD) is a chronic and incurable disease, of unknown etiology, associated with an unregulated immune response to environmental triggers in a genetically predisposed host. IBD affects mainly the gastrointestinal (GI) tract and includes Crohn's disease (CD) and ulcerative colitis (UC). However, a large percentage of patients may present with extraintestinal manifestations, including mucocutaneous ones (which are the most common) and dermatologic findings, such as erythema nodosum, pyoderma gangrenosum, and aphthous stomatitis (which are the most frequently occurring). According to pathophysiologic mechanisms, mucocutaneous manifestations of IBD are classified into five categories, namely, specific manifestations, associated manifestations, reactive manifestations, adverse effects of IBD therapy, and malabsorption manifestations. Recognizing such manifestations should not be performed only by a dermatologist but also other specialties such as internal medicine, gastroenterology, among others. This is because these manifestations can present before the IBD diagnosis, even in the absence of GI symptoms. Therefore, these skin lesions could be a fundamental tool for the earlier diagnosis of IBD. This review provides a comprehensive overview of the most common cutaneous manifestations of IBD with a focus on their epidemiology, diagnostic criteria, clinical presentation, and available medical treatment.
Keywords: cutaneous crohn’s disease; cutaneous manifestations of inflammatory bowel disease; extraintestinal manifestations in inflammatory bowel disease; inflammatory bowel disease; ulcerative colitis (uc).
Copyright © 2021, Alvarez-Payares et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

References
-
- Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Yu YR, Rodriguez JR. https://linkinghub.elsevier.com/retrieve/pii/S1055-8586(17)30106-3. Semin Pediatr Surg. 2017;26:349–355. - PubMed
-
- Early-onset inflammatory bowel disease. Kelsen JR, Russo P, Sullivan KE. https://linkinghub.elsevier.com/retrieve/pii/S1055-8586(17)30106-3. Immunol Allergy Clin North Am. 2019;39:63–79. - PMC - PubMed
-
- Inflammatory bowel disease. Shapiro JM, Subedi S, LeLeiko NS. Pediatr Rev. 2016;37:337–347. - PubMed
-
- Dermatologic manifestations of inflammatory bowel disease: a review. Keyal U, Liu Y, Bhatta AK. https://www.discoverymedicine.com/Uma-Keyal/2018/05/dermatologic-manifes... Discov Med. 2018;25(139):225–233. - PubMed
-
- Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Greuter T, Vavricka SR. Expert Rev Gastroenterol Hepatol. 2019;13:307–317. - PubMed
Publication types
LinkOut - more resources
Full Text Sources